1. Home
  2. VSEC vs CNTA Comparison

VSEC vs CNTA Comparison

Compare VSEC & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VSE Corporation

VSEC

VSE Corporation

HOLD

Current Price

$180.47

Market Cap

5.1B

ML Signal

HOLD

Logo Centessa Pharmaceuticals plc

CNTA

Centessa Pharmaceuticals plc

HOLD

Current Price

$39.60

Market Cap

6.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VSEC
CNTA
Founded
1959
2020
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.1B
6.1B
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
VSEC
CNTA
Price
$180.47
$39.60
Analyst Decision
Strong Buy
Buy
Analyst Count
7
9
Target Price
$226.29
$43.17
AVG Volume (30 Days)
470.7K
2.0M
Earning Date
05-05-2026
05-13-2026
Dividend Yield
0.25%
N/A
EPS Growth
N/A
29.13
EPS
1.04
N/A
Revenue
$760,113,000.00
$15,000,000.00
Revenue This Year
$32.16
N/A
Revenue Next Year
$21.36
N/A
P/E Ratio
$176.65
N/A
Revenue Growth
9.88
N/A
52 Week Low
$123.69
$10.95
52 Week High
$232.61
$40.26

Technical Indicators

Market Signals
Indicator
VSEC
CNTA
Relative Strength Index (RSI) 45.49 71.89
Support Level $159.08 $39.36
Resistance Level $229.74 $39.86
Average True Range (ATR) 10.45 0.15
MACD 0.55 -0.38
Stochastic Oscillator 39.40 47.52

Price Performance

Historical Comparison
VSEC
CNTA

About VSEC VSE Corporation

VSE Corp is a diversified aftermarket products and services company providing repair services, parts distribution, logistics, supply chain management, and consulting services for land, sea, and air transportation assets to commercial and government markets. Its operations include supply chain management solutions, parts supply and distribution, and maintenance, repair, and overhaul (MRO) services for vehicle fleet, aviation, maritime and other customers. Its reportable segments are; Aviation and Fleet. The majority of the revenue for the company is generated from the Aviation segment which is a provider of aftermarket parts distribution and MRO services for components and engine accessories supporting commercial, business, and general aviation operators.

About CNTA Centessa Pharmaceuticals plc

Centessa Pharmaceuticals PLC is a clinical-stage biotechnology company pioneering a new class of therapeutics in orexin-based neuroscience. The group is developing a franchise of small molecule orexin receptor 2 (OX2R) agonists designed to address neuroscience diseases underpinned by dysregulation of wakefulness, attention, cognition, mood, and other symptoms, each grounded in the shared biology of the orexin pathway. The company's programs and Pipeline are the Orexin Receptor 2 Agonist Program and LockBody Technology Platform.

Share on Social Networks: